Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 FY- Text added to 2015 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abatacept, Abbott, aberrancy, acetate, Actelion, aggressive, Alex, anifrolumab, anniversary, antimalarial, arthralgia, atacicept, attenuate, autoreactive, bankruptcy, belimumab, beta, blisibimod, blocker, Cayman, Cederboum, Celgene, civilian, cleanup, clearance, CNS, complementarity, composed, contaminated, correlate, cytokine, cytotoxic, Daphna, deconsolidation, Denmark, depot, disinterested, divestment, draft, Edna, Egypt, eighteen, elotuzumab, enthusiasm, epratuzumab, expiry, explicitly, exploring, extremist, Fas, feeling, fever, Finland, fired, forigerimod, gamma, graft, Gutman, Hal, heightened, heretofore, herewith, Hezbollah, Holland, idiotype, IFN, immunosuppression, immunosuppressive, impede, induction, instance, intervention, intramuscular, Invion, Iraq, irrespective, ISIL, Islamic, issuable, jihadist, Jordan, Lebanon, lesser, Leukemia, Levant, Liechtenstein, ligand, lupuzor, mAb, majeure, malaise, MedImmune, methotrexate, mice, mild, militia, Mintz, missile, moderate, modulation, noise, nose, nuclear, OECD, officially, opposed, panobinostat, parallel, Paran, Parenteral, pathogenic, peaceful, Peninsula, pleurisy, Privileged, prominent, radioactive, rash, rebel, relinquish, sequence, Sinai, sporadically, steroid, stringent, sublease, subset, suppressor, Syria, tabalumab, TGF, thalomide, threatened, Tikotsky, TNF, topical, turbulence, unadjusted, unaffiliated, unanticipated, unappealing, uncured, unpaid, unregistered, vitro, Vorinistat, waive, wastewater, water
Removed:
activityand, administering, Africa, aggravation, agitation, Amit, analog, antipsychotic, apathy, aproportion, Arab, arepreferred, arose, asfrontline, atypical, autologoushaematopoietic, bargain, basket, begin, border, bortezomibin, boycott, clarified, clause, cognitive, collectionof, complication, comprise, compromise, constipation, consume, conventional, core, cyclophosphamide, deal, deployment, depression, derecognition, deriving, derogate, dexamethasone, disturbing, doxorubicin, effectivein, emerging, emotional, emphasize, escalating, essence, exact, experiencing, extensively, facing, factor, faster, FDAbased, founding, fundamentally, gaon, generated, Giboov, Grossman, GSK, hasrecently, Hayehudim, Helsinki, hematologist, Hematology, Hereunder, Herzliya, hispro, hospitalization, hostility, Ichilov, immunological, improve, inhibit, inInternal, intensity, intention, intracellular, isunclear, lab, licensor, lifelong, Manchester, Marc, maximize, mechanismof, Medinat, melphalan, methylprednisolone, Mittelman, modern, modified, modulationof, mortality, Moshe, moved, murine, neighbor, neuropathy, noncompliance, North, notification, nowused, ofthalidomide, organelleresponsible, originating, owing, partially, PCT, perpetual, pioneering, potent, poverty, prednisone, prerequisite, Presidio, principle, prolong, prolonged, propensity, prospectively, proteasome, protected, protein, psychiatric, rated, ratesand, refractory, refractorydisease, regimenscontaining, relapse, release, remitting, renewal, renewed, replicated, resistant, respond, restriction, restructuring, Ronen, Sackler, schizophrenic, Shalvata, showing, Sourasky, sparingly, speaker, speech, stop, Strip, substitute, summarized, survive, synergisticwith, teratogenicity, tetracycline, thalidomide, thromboembolism, thrombophilia, tracing, Traditional, transplant, treatmentfor, trend, trustee, Twito, unlimited, unrecognized, URL, validated, vehicle, vincristine, VivoQuest, voluntarily, VTE, white
Valuein 2014 FY filing- Value in 2015 FY filing
Original filings
Filing view